Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination

Detalles Bibliográficos
Autores principales: Chhabra, Saurabh, Szabo, Aniko, Clurman, Annelie, McShane, Katelynn, Waters, Nicholas, Eastwood, Daniel, Samanas, Lisa, Fei, Teng, Armijo, Gabriel, Abedin, Sameen, Longo, Walter, Hari, Parameswaran, Hamadani, Mehdi, Shah, Nirav N., Runaas, Lyndsey, Jerkins, James H., van den Brink, Marcel, Peled, Jonathan U., Drobyski, William R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827178/
https://www.ncbi.nlm.nih.gov/pubmed/36106394
http://dx.doi.org/10.3324/haematol.2022.281309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827178/
https://www.ncbi.nlm.nih.gov/pubmed/36106394
http://dx.doi.org/10.3324/haematol.2022.281309

Ejemplares similares